Chr. Hansen Holding A/S Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 5/16/2023)
| Balance Sheet | Total Assets | 3,431,000,000.00 | ROE | – |
| Balance Sheet | Total Equity | 1,900,000,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -116,200,000.00 | P/FCF | – |
| Cashflow | Free Cash Flow | 200,700,000.00 | – | – |
| Cashflow | Operating Cash Flow | 316,900,000.00 | P/CF | – |
| Income | Earnings per Share (diluted) | 1.72 | Div. Yield | – |
| Income | Net Income | 226,760,000.00 | P/E | – |
| Income | Shares Outstanding | 131,000,000.00 | P/B | – |
| Income | Total Revenue | 1,332,970,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Founded in 1874 and newly listed in 2010 after five years of privately owned ownership, Chr. Hansen is a global life science company with more than 3,200 employees in 30 countries. The segments include Food Cultures and Enzymes, which manufacture and sell innovative cultures, enzymes and probiotic products that help determine the taste, taste, texture, shelf life, nutritional value and health benefits of a wide variety of consumer products in the food industry. especially in the dairy industry; and health and nutrition, which manufacture and sell products for the dietary supplement, over-the-counter pharmaceutical, infant nutrition, animal feed, and crop protection industries.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.chr-hansen.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more